Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients
Clinical trial NCT03141203 · COMPLETED
Trial details
- NCT number
- NCT03141203
- Sponsor
- University of Birmingham
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-13
- Primary completion
- 2020-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.